-
NEW YORK (Reuters Health) – While most women should undergo a needle biopsy for breast cancer diagnosis, some surgeons opt for open biopsies instead, a new study found. The difference may be a matter of surgeon experience, researchers say, […]
read more -
SAN DIEGO — Many people overestimate their exposure to ionizing radiation from mammography, a new study shows. Asked to compare the radiation dose from a mammogram to five other benchmarks, a sample of 1350 people (including 2 men) ranked […]
read more -
Almost one third of early-stage breast cancer survivors who were working when they began treatment were unemployed 4 years later, according to a new longitudinal American study. And chemotherapy was significantly associated with a heightened risk for that long-term […]
read more -
VIENNA — The risk of developing a primary lung cancer after radiotherapy for breast cancer increases in a dose-response manner, with these odds jumping 17-fold in smokers, according to new research from a cohort of more than 23,000 irradiated patients […]
read more -
NEW YORK (Reuters Health) – Despite some evidence that fertility treatments increase the risk of breast cancer, a large, long term study has found no added risk. Nearly 10,000 women who received drugs to stimulate ovulation were no more […]
read more -
NEW YORK (Reuters Health) – Buparlisib combined with letrozole shows promise in treating estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer, according to the early-phase Stand Up to Cancer study. “The combination of letrozole and buparlisib was overall safe and […]
read more -
Breast cancer mortality has declined across Europe, but there are still notable differences between countries, according to new data presented at the 9th European Breast Cancer Conference in Glasgow, United Kingdom. Researchers reported that the death rate from breast […]
read more -
NEW YORK (Reuters Health) – If girls and women of all ages adopted healthier lifestyle behaviors and the highest-risk women took preventive drugs like tamoxifen, the authors of a new report say fully half of breast cancers in the U.S. […]
read more -
In a first-of-its-kind clinical trial, physician-scientists at University Hospitals (UH) Case Medical Center are exploring a new method to potentially prevent recurrence of an early stage, aggressive type of breast cancer. The pilot study, conducted by Joe Baar, MD, Director […]
read more -
This early test of the two agents in a breast cancer model suggests that the double hit can stifle tumour progression, avoid drug resistance and cause few side effects, say researchers at the Ohio State University Comprehensive Cancer Center – […]
read more
